DE60232876D1 - Verfahren für die in-vitro-diagnostik oder für die überwachung einer krankheit mit entzündungsreaktion - Google Patents

Verfahren für die in-vitro-diagnostik oder für die überwachung einer krankheit mit entzündungsreaktion

Info

Publication number
DE60232876D1
DE60232876D1 DE60232876T DE60232876T DE60232876D1 DE 60232876 D1 DE60232876 D1 DE 60232876D1 DE 60232876 T DE60232876 T DE 60232876T DE 60232876 T DE60232876 T DE 60232876T DE 60232876 D1 DE60232876 D1 DE 60232876D1
Authority
DE
Germany
Prior art keywords
disease
monitoring
selenoprotein
inflammatory response
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60232876T
Other languages
English (en)
Inventor
Xavier Forceville
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Serenite - Forceville Suresnes Fr
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60232876D1 publication Critical patent/DE60232876D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/801—Electron dense compounds, e.g. ferritin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60232876T 2001-05-16 2002-05-15 Verfahren für die in-vitro-diagnostik oder für die überwachung einer krankheit mit entzündungsreaktion Expired - Lifetime DE60232876D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29097301P 2001-05-16 2001-05-16
PCT/EP2002/005350 WO2002093175A1 (en) 2001-05-16 2002-05-15 Methods and kits for the in vitro diagnostic or for the monitoring of a disease involving an inflammatory reaction

Publications (1)

Publication Number Publication Date
DE60232876D1 true DE60232876D1 (de) 2009-08-20

Family

ID=23118274

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60232876T Expired - Lifetime DE60232876D1 (de) 2001-05-16 2002-05-15 Verfahren für die in-vitro-diagnostik oder für die überwachung einer krankheit mit entzündungsreaktion

Country Status (10)

Country Link
US (1) US7695972B2 (de)
EP (1) EP1393078B1 (de)
JP (1) JP4196265B2 (de)
AT (1) ATE436023T1 (de)
BR (1) BR0209681A (de)
CA (1) CA2447601C (de)
DE (1) DE60232876D1 (de)
DK (1) DK1393078T3 (de)
ES (1) ES2329984T3 (de)
WO (1) WO2002093175A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6188929B2 (ja) 2014-04-22 2017-08-30 国立大学法人東北大学 肺高血圧症の検査方法
FR3037798A1 (fr) 2015-06-25 2016-12-30 Serenite-Forceville Composition comprenant au moins un compose selenie pour le traitement du sepsis et/ou de toute hyper-inflammation generalisee (sirs) ou cellulaire dommageable
CN108982875A (zh) * 2018-08-13 2018-12-11 张明程 硒蛋白p胶体金检测卡的制备与应用
JP2022514896A (ja) * 2018-12-20 2022-02-16 シュピーンゴテック ゲゼルシャフト ミット ベシュレンクテル ハフツング 心不全におけるセレノプロテインｐ
DE102020002289B4 (de) 2020-04-07 2023-08-17 selenOmed GmbH Selenoprotein P als Marker für eine Selenvergiftung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303295B1 (en) * 1995-07-14 2001-10-16 University Of Georgia Research Foundation, Inc. Selenoproteins, coding sequences and methods
FR2782642B1 (fr) * 1998-08-31 2001-12-07 Xavier Forceville Utilisation du selenium pour le traitement de patients atteints d'un syndrome de reponse inflammatoire systemique (sirs), et composition pour la mise en oeuvre du traitement
WO2000031131A1 (fr) * 1998-11-19 2000-06-02 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Fragments peptidiques a activite inhibitrice de la mort cellulaire

Also Published As

Publication number Publication date
CA2447601C (en) 2010-08-10
JP4196265B2 (ja) 2008-12-17
US7695972B2 (en) 2010-04-13
CA2447601A1 (en) 2002-11-21
EP1393078B1 (de) 2009-07-08
DK1393078T3 (da) 2009-11-16
ES2329984T3 (es) 2009-12-03
EP1393078A1 (de) 2004-03-03
ATE436023T1 (de) 2009-07-15
AU2002342870B2 (en) 2007-09-06
JP2004532415A (ja) 2004-10-21
US20040126822A1 (en) 2004-07-01
BR0209681A (pt) 2004-09-14
WO2002093175A1 (en) 2002-11-21

Similar Documents

Publication Publication Date Title
GB2381452B (en) Wound monitoring
DE602007013620D1 (de) Auf IP-10 basierende immunologische Überwachung
DK2073008T3 (da) Forbedrede immunoassayfremgangsmåder
DE502005007863D1 (de) P1gf und flt-1 als prognostische parameter bei kardiovaskulären erkrankungen
ATE447357T1 (de) Verfahren und vorrichtung zur frühdiagnose von subakuten, aber möglicherweise tödlichen krankheiten
EP1738689A3 (de) System und Verfahren für Monitoring von nichtinvasiver Glucose
DE602006021777D1 (de) Diagnoseverfahren für präeklampsie
RU2008103988A (ru) Способ диагностики рассеяного склероза
ATE476527T1 (de) Quantifizierungsverfahren für die vegf isoformen einer biologischen probe
EP2557421A3 (de) Veränderte mitochondriale Aktivität bei Krankheiten, die durch oxidativen Stress entstehen
KR950703147A (ko) 모니터링 방법(Monitoring Method)
DE60232876D1 (de) Verfahren für die in-vitro-diagnostik oder für die überwachung einer krankheit mit entzündungsreaktion
DE60239622D1 (de) Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechsel
JP7245174B2 (ja) 唾液のｈｇｆ及びｍｍｐ－８に基づく歯周炎の診断
DE50112675D1 (de) Sonde für die dielektrische und optische diagnostik
DE60232595D1 (de) Methode zur diagnose von nierenerkrankungen
CN1891144A (zh) 一种中风预警检测仪
DE602004013554D1 (de) Verbindungen und verfahren zur diagnose von prostatakrebs
EP3407070A1 (de) Diagnose von periodontitis auf basis von hgf und mmp-8 im speichel
EP3407068A1 (de) Diagnose von leichter oder fortgeschrittener parodontose auf basis von il-1beta und mmp-9 im speichel
PL422387A1 (pl) Sposób oznaczania wrażliwości tkanek na insulinę, sposób identyfikacji insulinooporności i/lub określania predyspozycji do zaburzenia z nią związanego, zastosowanie wskaźnika insulinowrażliwości oraz zestawy diagnostyczne i ich zastosowania
IL137308A0 (en) Conductivity-normalized urinary analyte concentration measurement for use in disease diagnosis
RU2005125380A (ru) Способ прогнозирования эффективности методов лечения заболеваний
EP3477306A1 (de) Klassifizierung von parodontitispatienten
TH127959B (th) ชุดน้ำยาตรวจโรคพยาธิแคปิลลาเรียในเคน (human capillariasis) และกรรมวิธี การผลิตชุดน้ำยาตรวจโรคดังกล่าว

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SERENITE - FORCEVILLE, SURESNES, FR

8364 No opposition during term of opposition